Cefotaxime sodium and Abdominal pain - a phase IV clinical study of FDA data


Abdominal pain is found among people who take Cefotaxime sodium, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Cefotaxime sodium and have Abdominal pain. It is created by eHealthMe based on reports of 2,199 people who have side effects when taking Cefotaxime sodium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 17, 2022

2,199 people reported to have side effects when taking Cefotaxime sodium.
Among them, 16 people (0.73%) have Abdominal pain.

What is Cefotaxime sodium?

Cefotaxime sodium has active ingredients of cefotaxime sodium. eHealthMe is studying from 2,200 Cefotaxime sodium users for its effectiveness, alternative drugs and more.

What is Abdominal pain?

Abdominal pain is found to be associated with 4,655 drugs and 4,854 conditions by eHealthMe.

Number of Cefotaxime sodium and Abdominal pain reports submitted per year:

Could Cefotaxime sodium cause Abdominal pain?

Time on Cefotaxime sodium when people have Abdominal pain *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Abdominal pain when taking Cefotaxime sodium *:

  • female: 35.71 %
  • male: 64.29 %

Age of people who have Abdominal pain when taking Cefotaxime sodium *:

  • 0-1: 0.0 %
  • 2-9: 30.77 %
  • 10-19: 7.69 %
  • 20-29: 7.69 %
  • 30-39: 0.0 %
  • 40-49: 23.08 %
  • 50-59: 0.0 %
  • 60+: 30.77 %

Common drugs people take besides Cefotaxime sodium *:

  1. Cancidas: 3 people, 18.75%
  2. Insulin: 3 people, 18.75%
  3. Fluconazole: 3 people, 18.75%
  4. Imipenem And Cilastatin: 2 people, 12.50%
  5. Myfortic: 2 people, 12.50%
  6. Chymotrypsin: 2 people, 12.50%
  7. Ciclosporin: 2 people, 12.50%
  8. Gentamicin: 1 person, 6.25%
  9. Aloxi: 1 person, 6.25%
  10. Ambisome: 1 person, 6.25%

Common side effects people have besides Abdominal pain *:

  1. Fever: 11 people, 68.75%
  2. Gastroenteritis (inflammation of stomach and intestine): 5 people, 31.25%
  3. Rashes (redness): 5 people, 31.25%
  4. C-Reactive Protein Increased: 5 people, 31.25%
  5. Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 5 people, 31.25%
  6. Hepatomegaly (abnormal enlargement of the liver): 4 people, 25.00%
  7. Gamma-Glutamyltransferase Increased: 4 people, 25.00%
  8. Itching: 4 people, 25.00%
  9. Leukopenia (less number of white blood cells in blood): 4 people, 25.00%
  10. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 25.00%

Common conditions people have *:

  1. Osteomyelitis (infection of bone): 4 people, 25.00%
  2. Infection: 3 people, 18.75%
  3. Weakness: 2 people, 12.50%
  4. Dizziness: 2 people, 12.50%
  5. Heart Disease: 2 people, 12.50%
  6. High Blood Pressure: 2 people, 12.50%
  7. Urination - Excessive Volume: 2 people, 12.50%
  8. Lung Disorder (lung disease): 2 people, 12.50%
  9. Pain: 2 people, 12.50%
  10. Productive Cough: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Cefotaxime sodium and have Abdominal pain?

Check whether Abdominal pain is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Abdominal pain and when was it recovered:

Expand to all the drugs that have ingredients of cefotaxime sodium:

Alternative drugs to, pros and cons of Cefotaxime sodium:

Common Cefotaxime sodium side effects:

Browse all side effects of Cefotaxime sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Abdominal pain treatments and more:

COVID vaccines that are related to Abdominal pain:

Common drugs associated with Abdominal pain:

All the drugs that are associated with Abdominal pain:

Common conditions associated with Abdominal pain:

All the conditions that are associated with Abdominal pain:

How the study uses the data?

The study uses data from the FDA. It is based on cefotaxime sodium (the active ingredients of Cefotaxime sodium) and Cefotaxime sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: